Apr 16, 2018 11:01 am UTC| Business
Geneva, Switzerland and Boston, MA - April 16, 2018- ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that...
Celldex’s METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint
Apr 16, 2018 11:01 am UTC| Business
HAMPTON, N.J., April 16, 2018 -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported that the Company’s randomized, Phase 2b METRIC Study of glembatumumab vedotin compared to Xeloda® (capecitabine) in patients with...
Apr 16, 2018 11:01 am UTC| Business
BERKELEY HEIGHTS, N.J., April 16, 2018 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases...
Apr 16, 2018 11:01 am UTC| Business
NEW YORK, April 16, 2018 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced expansion of its Board of Directors to include...
Apr 16, 2018 11:01 am UTC| Business
EXTON, Pa., April 16, 2018 -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel oligonucleotide...
IRADIMED CORPORATION to Hold 2018 First Quarter Financial Results Conference Call on April 30th
Apr 16, 2018 11:01 am UTC| Business
WINTER SPRINGS, Fla., April 16, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 first quarter financial results before the market opens on Monday, April 30th. IRADIMED...
Apr 16, 2018 11:01 am UTC| Business
CAMBRIDGE, Mass. and BEIJING, China, April 16, 2018 -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and...